Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.
about
Cell-free circulating tumor DNA in cancerNew concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkersCirculating DNA as biomarker in breast cancerNucleic acids in circulation: are they harmful to the host?Tracking genomic cancer evolution for precision medicine: the lung TRACERx studyCirculating Tumor DNA as Biomarkers for Cancer Detection.Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysisLiquid biopsy: monitoring cancer-genetics in the blood.Circulating free DNA in the management of breast cancer.Whole genome sequence analysis suggests intratumoral heterogeneity in dissemination of breast cancer to lymph nodesGenome aberrations in canine mammary carcinomas and their detection in cell-free plasma DNA.Influence of plasma processing on recovery and analysis of circulating nucleic acids.The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy.An emerging toolkit for targeted cancer therapies.The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancerBone marrow micrometastases in early breast cancer-30-year outcome.Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.The potential for liquid biopsies in the precision medical treatment of breast cancer.Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening.The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.Repurposing the Pap smear: one step closer to gynecologic cancer screening.What the blood knows: interrogating circulating tumor DNA to predict progression of minimal residual disease in early breast cancer.A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers.Circulating-free DNA Mutation Associated with Response of Targeted Therapy in Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast CancerTumor suppressor p53 induces miR-15a processing to inhibit neuronal apoptosis inhibitory protein (NAIP) in the apoptotic response DNA damage in breast cancer cellCirculating nucleic acids as biomarkers in breast cancer.Hide and seek: tell-tale signs of breast cancer lurking in the blood.Clinical opportunities and challenges in targeting tumour dormancy.Circulating tumour cells and cell-free DNA as tools for managing breast cancer.Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?The future of breast cancer systemic therapy: the next 10 years.The use of circulating biomarkers in early clinical trials in patients with cancer.Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsiesThe role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring.KSR1 regulates BRCA1 degradation and inhibits breast cancer growth.Microsatellite instability typing in serum and tissue of patients with colorectal cancer: comparing real time PCR with hybridization probe and high-performance liquid chromatography.The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring.Genetic variation in one-carbon metabolism in relation to genome-wide DNA methylation in breast tissue from heathy women.Non-invasive Analysis of Genomic Copy Number Variation in Patients with Hepatocellular Carcinoma by Next Generation DNA Sequencing.
P2860
Q26750899-D072D65C-28E0-4CE5-8E5B-5CB6EA6E2779Q26774577-3EB8033D-401E-4EF2-8E9A-380108646E61Q26785343-1C989F0F-0AA2-473C-923E-2C2B78279991Q27011448-EC943E45-D55C-4FC7-9FC8-AF93EED0EBA4Q28655985-1079A7B7-9D2B-4B48-B0FD-B95F4AE4CD54Q33632125-9BA44722-3C61-484B-8B0B-1CC85FC78BF9Q33688767-79A11805-C4E1-42A4-A3FF-5F14AE68504FQ34356149-7C44663A-F4EE-47A5-B86B-E02841B11B2CQ34357893-35EB78AB-6C52-4FA5-99D5-FFD2A9587784Q34784863-48B8F45D-D04B-4522-8836-4F60632B218AQ35010017-6D93AA1C-2B22-4DFF-8B6A-E8E579D3B1F6Q35035846-141DCC21-5D0D-48EB-AA98-4A5F0AE678D2Q35681975-96CAA9E6-5DD5-44D1-996F-B58426D7E12CQ35694357-6BF45DC5-FD8B-4299-A002-24676BA670D1Q36355823-2E94874A-7E05-41D3-BCE9-E3959D6A1409Q36547904-808B3FE3-2814-4DD6-9B92-F76C8975591EQ36557431-ACCE750D-2479-49F4-B7D1-7770DDF84AC6Q36849660-A09129C1-49DC-49F5-8E5B-407F6AEF07C7Q36903459-74272D0D-01C6-4B7F-9930-69E9C7196FD2Q37225239-894A0807-1F1B-4AD4-A9B3-38819290400AQ37300435-877EC7FE-70D8-430A-A7A8-4D6857CD1C92Q37583778-DDF7633C-4B5C-46B3-97B8-A9EC2FC3FF31Q37662783-D7B229CA-0E5F-4DFB-905F-AB8139483302Q37684125-6CE65356-64B2-4676-8BDB-C9C7FDF8FA2FQ37685289-CD9D9D8B-FC81-4275-8302-94170ED315E7Q37690204-75063F6D-6F2F-46A5-91A8-6E7529B881CBQ38056383-B2FEF9F6-9496-4CD5-BCEF-CB69C857C97AQ38062792-F587154E-F29A-427C-ACAF-D480DB68DFFCQ38109808-0CE5CABF-7EAA-4DBA-A04E-9795554846CEQ38152782-19CCC75D-611C-4ADF-97E0-5D6A1858433BQ38261856-274CCFB2-9A0E-47B6-9627-3B7E0CD79E4BQ38310565-55288F34-9896-45DD-85F0-74A4D0EEB0BEQ38600479-7B96394F-824B-49B2-A89C-F3541ABF047EQ38700222-F6DDA366-A175-4E54-ABFF-4F7727A8A460Q38825179-8171D2D9-8FC3-48A3-A364-BB3E64814B4FQ38987139-04159EE7-E5DB-45B9-95AF-49B0B9EA0E41Q39031616-1C26453E-C27B-4C16-9848-3BCD7C2B0815Q39183864-028BDFF2-2104-4AF4-96C6-8CDCBEA2D57EQ40862694-7429D133-E7CB-41A3-AA5B-A1F7BA97277FQ41494831-F9DDCC9A-BD66-4FF2-A441-98E24CD08050
P2860
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.
@ast
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.
@en
type
label
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.
@ast
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.
@en
prefLabel
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.
@ast
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.
@en
P2093
P2860
P356
P1433
P1476
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.
@en
P2093
Becky Ward
Carlo Palmieri
Chetana Ruangpratheep
Jacqueline A Shaw
James Brown
Justin Stebbing
Karen Page
Kevin Blighe
Natasha Hava
R Charles Coombes
P2860
P304
P356
10.1101/GR.123497.111
P577
2011-10-11T00:00:00Z